Please assess the completion status of the following clinical trial:

Trial Title: Combined Treatment for Alcohol-Dependent Individuals With PTSD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Males and females who are a minimum of 18 years and maximum of 65 years.~2. Participants meet Diagnostic and Statistical Manual Diploma in Social Medicine IV (DSM-IV) criteria for current alcohol misuse, abuse or dependence.~3. Participants must have current alcohol use over past 90 days defined by more than or equal to 2 heavy drinking days or more than or equal to 14 drinks over 30 consecutive days or abstinence less than or equal to 21 consecutive days.~4. Participants meet criteria for full or subthreshold PTSD. Subthreshold PTSD criteria differs from full PTSD in that the individual meets cluster C (numbing) OR cluster D (hyperarousal) whereas full PTSD requires that the individual meets both cluster C and D.~5. Participants demonstrate no gross organic mental syndrome.~6. Participants are capable of giving informed consent and capable of complying with study procedures.~7. Participants speak English.~Exclusion Criteria:~1. Individuals who are at significant risk for suicide based on their current mental state or history.~2. Participants with other current Axis I psychiatric disorders that, in the investigators' judgment, are unstable and would be disrupted by study medications. Current diagnosis of Bipolar I and psychotic disorders are exclusionary.~3. Participants who are currently severely depressed.~4. Participants with a history of psychosis or mania.~5. Participants with organic mental syndrome.~6. Participants physiologically dependent on any substance other than alcohol (excluding nicotine or caffeine or medically stable and managed methadone).~7. Participants with comorbid substance abuse disorder who require detoxification treatment.~8. Participants with unstable or significant physical disorders (e.g., uncontrolled hypertension, poorly-controlled diabetes, alanine aminotransferase/aspartate aminotransaminase (AST/ALT) three times the upper limit of normal) that would increase the risk of study participation.~9. Participants with a known history of seizures (not related to alcohol withdrawal).~10. Participants with moderate to severe alcohol withdrawal that would require pharmacological intervention.~11. Participants currently taking prescribed psychotropic medication that is contraindicated for use with sertraline (e.g. antidepressant medications except for mirtazapine or trazodone when used for the treatment of insomnia ) and/or psychotropic medications where the participant has not achieved a stabilized regimen. Participants that are stable on medications that are not contraindicated with the use of sertraline (e.g., Methadone or Adderall) will not be excluded.~12. A history of an allergic reaction to sertraline.~13. Women who are currently pregnant or are trying to get pregnant or are nursing or are pre-menopausal and sexually active but not using effective birth control.~14. Participants refusing to be audio or videotaped.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1) Seeking Safety + Sertraline (Type: ACTIVE_COMPARATOR): Seeking Safety + Sertraline
- 2) Seeking Safety + Placebo (Type: PLACEBO_COMPARATOR): Seeking Safety + Placebo;

Based on this trial design, predict the completion outcome and termination type (if applicable).